| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alagille Syndrome | 4 | 2019 | 47 | 1.240 |
Why?
|
| DNA Copy Number Variations | 15 | 2024 | 941 | 1.030 |
Why?
|
| Mosaicism | 6 | 2024 | 240 | 0.890 |
Why?
|
| Haplotypes | 2 | 2024 | 517 | 0.850 |
Why?
|
| Polymerase Chain Reaction | 2 | 2024 | 1584 | 0.830 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2024 | 2582 | 0.730 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 140 | 0.690 |
Why?
|
| Neurodevelopmental Disorders | 6 | 2024 | 485 | 0.680 |
Why?
|
| Genetic Markers | 2 | 2019 | 605 | 0.670 |
Why?
|
| Pedigree | 14 | 2023 | 1581 | 0.620 |
Why?
|
| Gene Duplication | 5 | 2024 | 358 | 0.610 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 327 | 0.590 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2015 | 281 | 0.590 |
Why?
|
| Comparative Genomic Hybridization | 8 | 2024 | 574 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2020 | 3077 | 0.540 |
Why?
|
| Phenotype | 11 | 2024 | 4227 | 0.540 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 309 | 0.510 |
Why?
|
| Intellectual Disability | 5 | 2023 | 1042 | 0.510 |
Why?
|
| Mutation | 13 | 2022 | 5772 | 0.500 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2015 | 40 | 0.500 |
Why?
|
| Membrane Proteins | 4 | 2020 | 1523 | 0.490 |
Why?
|
| Exome | 6 | 2020 | 1041 | 0.470 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 346 | 0.470 |
Why?
|
| Biliary Atresia | 4 | 2020 | 187 | 0.450 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 208 | 0.450 |
Why?
|
| Tetralogy of Fallot | 1 | 2015 | 161 | 0.450 |
Why?
|
| Gene Rearrangement | 5 | 2024 | 327 | 0.440 |
Why?
|
| Jagged-1 Protein | 4 | 2019 | 51 | 0.440 |
Why?
|
| Genome, Human | 4 | 2024 | 1264 | 0.440 |
Why?
|
| Chromosome Inversion | 2 | 2024 | 76 | 0.410 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2024 | 861 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2024 | 119 | 0.370 |
Why?
|
| Arthrogryposis | 2 | 2022 | 33 | 0.360 |
Why?
|
| Mutation, Missense | 3 | 2020 | 846 | 0.360 |
Why?
|
| Heterozygote | 4 | 2020 | 672 | 0.350 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2024 | 306 | 0.350 |
Why?
|
| Heterotaxy Syndrome | 2 | 2024 | 62 | 0.330 |
Why?
|
| Urogenital Abnormalities | 2 | 2023 | 169 | 0.330 |
Why?
|
| Chromosome Duplication | 2 | 2021 | 147 | 0.320 |
Why?
|
| Genomic Structural Variation | 3 | 2024 | 79 | 0.320 |
Why?
|
| Genomics | 6 | 2022 | 1475 | 0.310 |
Why?
|
| Humans | 48 | 2024 | 123092 | 0.310 |
Why?
|
| Microcephaly | 2 | 2023 | 328 | 0.300 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2018 | 57 | 0.300 |
Why?
|
| Receptor, Notch2 | 2 | 2019 | 8 | 0.290 |
Why?
|
| Abnormalities, Multiple | 3 | 2022 | 964 | 0.280 |
Why?
|
| Serrate-Jagged Proteins | 3 | 2015 | 38 | 0.280 |
Why?
|
| Whole Genome Sequencing | 4 | 2024 | 281 | 0.260 |
Why?
|
| Genetic Association Studies | 5 | 2020 | 761 | 0.250 |
Why?
|
| Translocation, Genetic | 2 | 2024 | 352 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 63 | 0.230 |
Why?
|
| Rare Diseases | 2 | 2024 | 186 | 0.220 |
Why?
|
| Genomic Instability | 2 | 2022 | 229 | 0.220 |
Why?
|
| Male | 26 | 2024 | 60091 | 0.220 |
Why?
|
| Gene Deletion | 2 | 2017 | 793 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2020 | 248 | 0.210 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 22 | 0.210 |
Why?
|
| Homologous Recombination | 2 | 2020 | 92 | 0.210 |
Why?
|
| Female | 26 | 2024 | 65538 | 0.210 |
Why?
|
| Fluorescent Dyes | 1 | 2024 | 260 | 0.210 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 132 | 0.210 |
Why?
|
| Myokymia | 1 | 2022 | 8 | 0.210 |
Why?
|
| Contracture | 1 | 2022 | 24 | 0.200 |
Why?
|
| Polydactyly | 1 | 2022 | 17 | 0.200 |
Why?
|
| Software | 2 | 2024 | 676 | 0.200 |
Why?
|
| Apyrase | 1 | 2022 | 18 | 0.200 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 29 | 0.200 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2022 | 39 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 245 | 0.200 |
Why?
|
| Megalencephaly | 1 | 2022 | 58 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 73 | 0.190 |
Why?
|
| Cation Transport Proteins | 1 | 2022 | 96 | 0.190 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 106 | 0.190 |
Why?
|
| Karyotyping | 2 | 2020 | 330 | 0.190 |
Why?
|
| Neoplasms | 1 | 2015 | 2758 | 0.180 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 1638 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 510 | 0.180 |
Why?
|
| Alu Elements | 1 | 2021 | 64 | 0.180 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 43 | 0.180 |
Why?
|
| Symporters | 1 | 2021 | 66 | 0.180 |
Why?
|
| DNA End-Joining Repair | 1 | 2020 | 34 | 0.180 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 64 | 0.180 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 36 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2020 | 92 | 0.180 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 45 | 0.170 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2020 | 67 | 0.170 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 35 | 0.170 |
Why?
|
| Homozygote | 4 | 2024 | 534 | 0.170 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2019 | 27 | 0.170 |
Why?
|
| Lissencephaly | 1 | 2019 | 10 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 181 | 0.170 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 77 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 105 | 0.170 |
Why?
|
| Dwarfism | 1 | 2020 | 101 | 0.170 |
Why?
|
| Muscle, Smooth | 1 | 2020 | 136 | 0.170 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 3 | 0.170 |
Why?
|
| Glycine Agents | 1 | 2019 | 10 | 0.160 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 7 | 0.160 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 73 | 0.160 |
Why?
|
| Chromosome Aberrations | 2 | 2021 | 614 | 0.160 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 194 | 0.160 |
Why?
|
| RNA Helicases | 1 | 2019 | 63 | 0.160 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 1806 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 244 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 165 | 0.150 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 136 | 0.150 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 142 | 0.150 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 118 | 0.150 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 239 | 0.150 |
Why?
|
| Glycine | 1 | 2019 | 167 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2020 | 135 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 124 | 0.150 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 148 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 147 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 106 | 0.150 |
Why?
|
| Child | 12 | 2024 | 24231 | 0.150 |
Why?
|
| Sequence Deletion | 2 | 2021 | 527 | 0.140 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 793 | 0.140 |
Why?
|
| Cholesterol | 1 | 2020 | 525 | 0.140 |
Why?
|
| DNA Repair | 1 | 2020 | 579 | 0.140 |
Why?
|
| Risperidone | 1 | 2017 | 60 | 0.140 |
Why?
|
| Infant | 10 | 2021 | 12357 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 757 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1114 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 448 | 0.130 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8111 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 65 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 28 | 0.120 |
Why?
|
| Hypopituitarism | 1 | 2015 | 15 | 0.120 |
Why?
|
| Twins, Monozygotic | 1 | 2015 | 117 | 0.120 |
Why?
|
| Mitochondria | 1 | 2020 | 677 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 667 | 0.120 |
Why?
|
| Siblings | 1 | 2015 | 196 | 0.120 |
Why?
|
| Environment | 1 | 2015 | 142 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 350 | 0.120 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2015 | 224 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2015 | 330 | 0.110 |
Why?
|
| Hypoxia | 1 | 2015 | 247 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 375 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2024 | 13884 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 65 | 0.110 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2013 | 63 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 398 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2019 | 1477 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 626 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2024 | 1753 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2021 | 4703 | 0.100 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 123 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 674 | 0.100 |
Why?
|
| Young Adult | 6 | 2021 | 8839 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2015 | 363 | 0.100 |
Why?
|
| Placenta | 1 | 2015 | 493 | 0.090 |
Why?
|
| Alleles | 3 | 2024 | 1604 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 314 | 0.090 |
Why?
|
| Base Sequence | 1 | 2015 | 3093 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 2054 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2021 | 371 | 0.080 |
Why?
|
| Adult | 8 | 2021 | 29018 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 864 | 0.070 |
Why?
|
| Adolescent | 6 | 2021 | 19104 | 0.070 |
Why?
|
| Animals | 6 | 2024 | 33794 | 0.070 |
Why?
|
| Pan troglodytes | 1 | 2024 | 71 | 0.060 |
Why?
|
| Liver | 3 | 2018 | 1736 | 0.060 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.060 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 14 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2024 | 118 | 0.060 |
Why?
|
| Bicarbonates | 1 | 2023 | 98 | 0.060 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 52 | 0.050 |
Why?
|
| Parents | 2 | 2020 | 1031 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 26 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 58 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 222 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 22 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 177 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 291 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 21 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 92 | 0.050 |
Why?
|
| Consanguinity | 1 | 2022 | 107 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 175 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 83 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 91 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 115 | 0.050 |
Why?
|
| Turkey | 1 | 2021 | 58 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 17541 | 0.050 |
Why?
|
| X Chromosome Inactivation | 1 | 2021 | 63 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 129 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 192 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2022 | 2585 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 262 | 0.050 |
Why?
|
| Peru | 1 | 2020 | 45 | 0.050 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2021 | 77 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2021 | 157 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 530 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 168 | 0.040 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 13 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 59 | 0.040 |
Why?
|
| Corneal Opacity | 1 | 2020 | 23 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2020 | 62 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 176 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 80 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 125 | 0.040 |
Why?
|
| Connectin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 424 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 555 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 163 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2019 | 66 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 29 | 0.040 |
Why?
|
| Axons | 1 | 2022 | 381 | 0.040 |
Why?
|
| Tubulin | 1 | 2019 | 106 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 195 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 120 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 141 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 99 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2020 | 83 | 0.040 |
Why?
|
| Gastroparesis | 1 | 2020 | 66 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 185 | 0.040 |
Why?
|
| Retina | 1 | 2022 | 456 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 239 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 197 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 153 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 713 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 480 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 268 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 414 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 594 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 101 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 120 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 2535 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 577 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 427 | 0.040 |
Why?
|
| Organogenesis | 1 | 2018 | 77 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2019 | 128 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2020 | 834 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 313 | 0.040 |
Why?
|
| Radiography | 1 | 2020 | 822 | 0.040 |
Why?
|
| Family | 1 | 2020 | 570 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2526 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 25993 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 233 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1591 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 282 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1115 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 239 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 545 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2020 | 296 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 332 | 0.030 |
Why?
|
| NIMA-Related Kinases | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 831 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 3720 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2696 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1590 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 478 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1566 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1138 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2404 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 211 | 0.030 |
Why?
|
| Facies | 1 | 2015 | 155 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 1018 | 0.030 |
Why?
|
| Seizures | 1 | 2020 | 872 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 581 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2013 | 19 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1797 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3240 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 309 | 0.030 |
Why?
|
| Rats | 1 | 2018 | 3653 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1081 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1012 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 1235 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1935 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1335 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2961 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6027 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 7162 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12119 | 0.010 |
Why?
|
| United States | 1 | 2013 | 10645 | 0.010 |
Why?
|